Form4insider filings, from the source

Insider holders · CIK 0001034842

RIGEL PHARMACEUTICALS INC · RIGL

Every insider with a reported Table I holding at this company, ranked by their last-reported share count. A balance is only as fresh as its filing — the report date sits next to every row on purpose. ← Back to activity

InsiderDirect sharesIndirect sharesTotal reportedLast report (ET)From
Raul R RodriguezCEO, President273,362—273,362Sep 3, 2026 · 6:59 pm EDTForm 4
Eldon C. Mayer IIIEVP & Chief Commercial Officer215,000—215,000Sep 12, 2018 · 7:48 pm EDTForm 4
Donald G PayanEVP, Pres. Discovery&Research58,33453,031111,365Sep 1, 2016 · 6:18 pm EDTForm 4
Dean L SchornoEVP & Chief Financial Officer82,962—82,962Sep 3, 2026 · 7:02 pm EDTForm 4
David A SantosEVP, Chief Commercial Officer61,622—61,622Sep 3, 2026 · 7:01 pm EDTForm 4
Raymond J. FureyEVP, GC, CCO & Corp Sec50,559—50,559Sep 3, 2026 · 6:59 pm EDTForm 4
Alison L. HannahEVP, Chief Medical Officer35,025—35,025Jul 10, 2026 · 9:53 pm EDTForm 4
Lisa RojkjaerEVP, Chief Medical Officer34,003—34,003Jun 3, 2026 · 6:02 pm EDTForm 4
Esteban MasudaSr. VP Research15,478—15,478Oct 11, 2016 · 8:56 pm EDTForm 3
Kamil Ali-JacksonDirector10,125—10,125Jun 24, 2026 · 4:04 pm EDTForm 4
Joseph LasagaVP Bus. Dev.& Alliance Mgmt.500—500Oct 11, 2016 · 8:49 pm EDTForm 3
Nelson CabatuanPrincipal Accounting Officer58—58Oct 16, 2018 · 6:46 pm EDTForm 4
Anne-Marie DuliegeEVP & Chief Medical Officer0—0Sep 19, 2018 · 6:26 pm EDTForm 4
Ryan D MaynardEVP & CFO0—0Nov 7, 2017 · 9:07 pm ESTForm 4

Balances come from each insider’s most recent filing that reports a Table I holding; an insider who left the company years ago still appears with their last-known figure and its date. Indirect totals collapse multiple vehicles (trusts, LLCs) into one number — open the filing for the breakdown. Shares as filed, not split-adjusted.